We blocked microglial proliferation for 4 weeks using the CSF1R tyrosine kinase inhibitor (GW2580), and demonstrated a reduction in neurogenesis that supports the hypothesis that microglia have a net pro-neurogenic effect during prion disease. Here, CSF1R is linked to prion disease.